Abstract A067: Precision medicine-oriented analysis of RTK-RAS signaling in gemcitabine-treated pancreatic cancer using conversational artificial intelligence
Although KRAS mutations represent the hallmark genomic alteration in pancreatic ductal adenocarcinoma (PDAC), the broader receptor tyrosine kinase RTK-RAS signaling landscapes underlying differential responses to gemcitabine remain poorly defined. We performed an integrative clinical-genomic analysis of 15...